Add like
Add dislike
Add to saved papers

Inheritance and fitness costs of Spodoptera frugiperda (Lepidoptera: Noctuidae) resistance to spinosad in Brazil.

BACKGROUND: Spodoptera frugiperda is a pest of economically important crops in South America. In Brazil, this species is considered the most destructive pest of maize. Use of spinosyn insecticides in insect resistance management (IRM) has been one strategy to control this pest. In this study, we selected a strain of S. frugiperda resistant to spinosad and evaluated the inheritance and fitness costs of the resistance.

RESULTS: Estimated LC50 (concentration required to kill 50% of larvae) values were 0.011 and 9.80 µg cm-2 for the spinosad-susceptible (Sus) and -resistant (Spin-res) strains, respectively. This represents an 890-fold resistance ratio. LC50 values for reciprocal crosses were 0.18 and 0.14 µg cm-2 , indicating that resistance to spinosad is an autosomal incompletely recessive trait. Backcrosses of the F1 progeny from reciprocal crosses with the parental Spin-res strain showed a polygenic effect. The estimated minimum number of independent segregations was ∼ 2.45, indicating that resistance to spinosad is associated with multiple genes. In greenhouse assays, third-instar larvae from the Spin-res strain showed >92% survival on spinosad-treated maize. By contrast Sus and reciprocal crosses exhibited 0% and <5% survival, respectively, indicating that resistance is recessive. Life history studies to investigate the fitness cost of resistance revealed a 41% reduction in the rate of survival to adulthood and a 49% lower reproductive rate in the Spin-res strain compared with the Sus strain.

CONCLUSIONS: The autosomal, incompletely recessive and polygenic resistance to spinosad in S. frugiperda and the fitness costs associated with this resistance can be exploited in IRM strategies to preserve the lifetime of spinosad for control of S. frugiperda in Brazil. © 2017 Society of Chemical Industry.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app